Pediatric Stem Cell Transplantation Expert and Industry Leader Dr. Joseph Rosenthal Joins Cell Source’s Scientific Advisory Board
NEW YORK, Feb. 25, 2021 /PRNewswire/ --Â Cell Source, Inc. (OTC: CLCS) ("Cell Source" or the "Company"), a developer of Veto Cell-based innovative immunotherapy technologies that facilitate mismatched donor stem cell
Transplant News